- Report
- November 2021
- 156 Pages
Global
From €4963EUR$5,560USD£4,316GBP
€6204EUR$6,950USD£5,395GBP
- Report
- January 2024
- 257 Pages
Global
From €4463EUR$5,000USD£3,881GBP
- Report
- May 2024
- 134 Pages
Global
From €5802EUR$6,499USD£5,044GBP
- Report
- May 2024
- 135 Pages
Global
From €5802EUR$6,499USD£5,044GBP
- Report
- December 2024
- 85 Pages
Spain
From €3124EUR$3,500USD£2,717GBP
- Report
- November 2023
- 77 Pages
France
From €3124EUR$3,500USD£2,717GBP
- Report
- October 2023
- 183 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- October 2023
- 138 Pages
North America
From €3571EUR$4,000USD£3,105GBP
- Report
- June 2024
- 165 Pages
Global
From €2232EUR$2,500USD£1,940GBP
- Report
- April 2023
- 115 Pages
Global
From €4240EUR$4,750USD£3,687GBP
- Report
- November 2024
- 67 Pages
From €3080EUR$3,450USD£2,678GBP
- Report
- August 2024
- 170 Pages
Global
From €3973EUR$4,450USD£3,454GBP
- Report
- April 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,841GBP
- Report
- May 2023
- 147 Pages
Global
From €4418EUR$4,949USD£3,841GBP
From €106EUR$119USD£92GBP
- Book
- August 2021
- 312 Pages
- Book
- July 2024
North America

Head and neck cancer is a type of cancer that affects the head and neck region, including the mouth, throat, nose, and salivary glands. It is a subset of oncology, the branch of medicine that deals with the diagnosis and treatment of cancer. Treatment for head and neck cancer typically involves surgery, radiation therapy, and chemotherapy. Depending on the type and stage of the cancer, a combination of these treatments may be used.
Head and neck cancer is a growing area of oncology, with new treatments and technologies being developed to improve outcomes for patients. Research is ongoing to better understand the causes of head and neck cancer and to develop more effective treatments.
Companies in the head and neck cancer market include AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, Roche, and Sanofi. Show Less Read more